TY - JOUR
T1 - Polycaprolactone-based in situ implant containing curcumin-PLGA nanoparticles prepared using the multivariate technique
AU - Kasinathan, Narayanan
AU - Amirthalingam, Muthukumar
AU - Reddy, Neetinkumar D.
AU - Vanthi, Meenashi B.
AU - Volety, Subrahmanyam M.
AU - Rao, Josyula Venkata
PY - 2016/8/17
Y1 - 2016/8/17
N2 - Studies on the effect of curcumin/PLGA ratio (CPR), stabilizer (PVA) concentration, homogenization speed, homogenization time, and sonication time on mean particle size (MPS) and percentage drug encapsulation (PDE) were performed using the multivariate technique. MPS and PDE were found to be more dependent on the interaction of sonication time with the other variables. Curcumin was released in a sustained manner from curcumin-PLGA nanoparticles (CPN). CPN improved the survival rate of Ehrlich ascites carcinoma (EAC)-bearing mice and controlled the EAC-induced change in hematological parameters. Histopathology of vital organs showed that the formulation was safe. Polycaprolactone was used in preparing an in situ implant containing CPN.
AB - Studies on the effect of curcumin/PLGA ratio (CPR), stabilizer (PVA) concentration, homogenization speed, homogenization time, and sonication time on mean particle size (MPS) and percentage drug encapsulation (PDE) were performed using the multivariate technique. MPS and PDE were found to be more dependent on the interaction of sonication time with the other variables. Curcumin was released in a sustained manner from curcumin-PLGA nanoparticles (CPN). CPN improved the survival rate of Ehrlich ascites carcinoma (EAC)-bearing mice and controlled the EAC-induced change in hematological parameters. Histopathology of vital organs showed that the formulation was safe. Polycaprolactone was used in preparing an in situ implant containing CPN.
UR - http://www.scopus.com/inward/record.url?scp=84982965471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84982965471&partnerID=8YFLogxK
U2 - 10.3109/21691401.2015.1058810
DO - 10.3109/21691401.2015.1058810
M3 - Article
C2 - 26121330
AN - SCOPUS:84982965471
SN - 2169-1401
VL - 44
SP - 1520
EP - 1528
JO - Artificial Cells, Nanomedicine and Biotechnology
JF - Artificial Cells, Nanomedicine and Biotechnology
IS - 6
ER -